article = {COR-2019-6-103}
title = {Graviola in Metastatic Ovarian Cancer: A Case Report of Sustained Disease Stability}
journal = {Clinical Oncology and Research}
year = {2019}
issn = {2613-4942}
doi = {http://dx.doi.org/10.31487/j.COR.2019.06.03}
url = {https://www.sciencerepository.org/graviola-in-metastatic-ovarian-cancer-a-case-report-of-sustained-disease-stability_COR-2019-6-103 
author = {Philip Beale,Sarah Syed,Thi Thuy Duong Pham,}
keywords = {Metastatic ovarian cancer, complementary medicine, graviola, Annona muricata}
abstract ={Treatments for metastatic ovarian cancer to date have been limited by advanced stages at diagnosis,
drug toxicity and resistance. Cancer patients are also increasingly looking towards complementary
and alternative therapies. Graviola (Annona muricata) has traditionally been used in many conditions
including cancer, and both in vivo and in vitro studies have shown evidence of anti-cancer effects.
We present a case of a patient with metastatic ovarian cancer who progressed through multiple lines
of chemotherapy but had a response and sustained stability in Ca-125 levels whilst taking graviola
tablets. Further clinical research is warranted to evaluate graviola’s role in cancer therapy.
}